To get ready for 2010, I’ve put together a new calendar of expected U.S. Food and Drug Administration approval decisions. These can be make-or-break events for drug and biotech companies, so naturally, FDA decisions often move stocks significantly. The following calendar covers most of the expected drug approval decisions by the FDA through the end [...]